Zhang Ziyan, Liu Qiaojuan, Tan Jizhou, Zhan Xiaoxia, Liu Ting, Wang Yuting, Lu Gen, Wu Minhao, Zhang Yuanqing
School of Pharmaceutical Sciences, Sun Yat-sen University, Guangzhou 510006, China.
National and Local United Engineering Lab of Druggability and New Drugs Evaluation, Sun Yat-sen University, Guangzhou 510006, China.
Acta Pharm Sin B. 2021 Jul;11(7):1965-1977. doi: 10.1016/j.apsb.2021.04.002. Epub 2021 Apr 5.
Adoptive cell therapy (ACT) is an emerging powerful cancer immunotherapy, which includes a complex process of genetic modification, stimulation and expansion. During these or manipulation, sensitive cells are inescapability subjected to harmful external stimuli. Although a variety of cytoprotection strategies have been developed, their application on ACT remains challenging. Herein, a DNA network is constructed on cell surface by rolling circle amplification (RCA), and T cell-targeted trivalent tetrahedral DNA nanostructure is used as a rigid scaffold to achieve high-efficient and selective coating for T cells. The cytoprotective DNA network on T-cell surface makes them aggregate over time to form cell clusters, which exhibit more resistance to external stimuli and enhanced activities in human peripheral blood mononuclear cells and liver cancer organoid killing model. Overall, this work provides a novel strategy for T cell-selective protection, which has a great potential for application in ACT.
过继性细胞疗法(ACT)是一种新兴的强大癌症免疫疗法,它包括基因改造、刺激和扩增等复杂过程。在这些过程或操作中,敏感细胞不可避免地会受到有害的外部刺激。尽管已经开发出多种细胞保护策略,但它们在ACT上的应用仍然具有挑战性。在此,通过滚环扩增(RCA)在细胞表面构建DNA网络,并使用靶向T细胞的三价四面体DNA纳米结构作为刚性支架,以实现对T细胞的高效和选择性包被。T细胞表面的细胞保护DNA网络使它们随着时间的推移聚集形成细胞簇,这些细胞簇在人外周血单核细胞和肝癌类器官杀伤模型中表现出对外部刺激更强的抵抗力和增强的活性。总体而言,这项工作为T细胞选择性保护提供了一种新策略,在ACT中具有巨大的应用潜力。